跳至主要内容
临床试验/EUCTR2007-004513-33-GB
EUCTR2007-004513-33-GB进行中(未招募)1 期

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression - CEQUE

niversity of Oxford0 个研究点目标入组 202 人开始时间: 2008年3月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
202

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • For randomisation:
  • 1. primary diagnosis of DSM-IV bipolar disorder type I or II
  • 2. consent to randomisation
  • 3. aged 16 or over
  • 4. current depressive episode requiring new pharmacological treatment
  • 5. Quick Inventory of Depressive Symptomatology, self-report version (QIDS-SR16) score at least 11
  • 6. uncertainty whether quetiapine plus lamotrigine would be more effective than quetiapine monotherapy
  • 7. ability to tolerate quetiapine at a dose of at least 150mg/day
  • 8. acceptable adherence to quetiapine (>90%) and self-report SMS satisfactory
  • 9. Willing to accepr random allocation of treatments
  • 10. in the opinion of the investigator, not currently experiencing manic or mixed episode.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • For randomisation:
  • 1. definite indications or contraindications to lamotrigine, quetiapine or folic acid* (including pregnancy and planned pregnancy)
  • 2. new course of specific psychosocial intervention started in the past four weeks
  • 3. first appointment for specific psychosocial intervention booked within the next 14 weeks
  • 4. currently experiencing manic or mixed episode
  • 5. primary diagnosis of schizophrenia
  • Plus, for women of child-bearing potential
  • 6.not using adequate contraception or currently breast feeding.
  • * if contraindications are to folic acid/placebo only the person can enter the trial and be randomly allocated lamotrigine/placebo but not folic acid/placebo.

研究者

相似试验